Clinical Trials Directory

Trials / Unknown

UnknownNCT02446210

Neuroplasticity After Spinal Cord Injury

Targeted Neuroplasticity After Spinal Cord Injury

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
514 (estimated)
Sponsor
Shirley Ryan AbilityLab · Academic / Other
Sex
All
Age
18 Years – 85 Years
Healthy volunteers
Accepted

Summary

The long-term goal is to acquire scientific knowledge that can be used to develop mechanistic-driven intervention strategies aiming at restoring upper and lower-limb motor function in individuals with cervical or thoracic spinal cord injury (SCI). The proposed project will examine cortical, corticospinal, and spinal contribution to bilateral hand and arm muscle activity during bilateral movements and spinal contributions to lower limb muscle activity. By comparing changes in different sites within the Central Nervous System (CNS), the investigators may also identify key mechanisms that might be differentially affected by the injury, plasticity, and training.

Detailed description

If the participant qualifies to take part in this research study, they will be asked to participate in 15-190 study visits,to complete the experimental procedures. These procedures have been broken up into "Phases" and will be completed in any order. Phase I and Phase IIa includes 2-30 total visits - approximately 2-3 hours each to measure arm and finger strength and ability to move. Phase IIb includes 2-30 total visits - approximately 2-3 hours each, to measure leg strength and ability to move. Phase IIIa includes up to 40 total visits - approximately 2 hours each, the investigator will again evaluate the participant's ability to use both arms. The participant will be asked to complete a series of tasks such as stacking checkers, turning over cards, squeeze a device to determine how strong their grip is, and see how well they are able to feel sensations on the surface of their skin. The investigators will complete these assessments at pre-determined times during the study participation. Phase IIIb includes up to 40 total visits - approximately 2 hours each, the investigator will again evaluate the participant's ability to use both legs. Assessments of the participant's legs will include walking around the lab space, how well they can bend their ankles and hips, and how well they are able to feel sensations on the surface of the participant's skin.

Conditions

Interventions

TypeNameDescription
DEVICEMagstim 200Transcranial Magnetic Stimulation
DEVICEDigitimer electrical stimulatorTranscranial Magnetic Stimulation paired with Electrical Peripheral Nerve Stimulation

Timeline

Start date
2021-01-28
Primary completion
2022-01-27
Completion
2023-01-27
First posted
2015-05-18
Last updated
2021-05-25

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT02446210. Inclusion in this directory is not an endorsement.